Patients with a level of serum VEGF-D higher than 800 ng/L can be diagnosed as having LAM, and up to 70% of patients may avoid unnecessary invasive examination, while about 30% of patients with cystic lung diseases still need a lung biopsy for diagnosis. This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.